Cancer Prevention and Research Institute of Texas | GenomeWeb

Cancer Prevention and Research Institute of Texas

The funding is part of a total of $16.6 million from CPRIT to support cancer research at and recruit scientists to the medical center.  

The registry is expected to yield a "validated, semi-quantitative risk assessment algorithm that will assist physicians in managing patients at risk for ovarian cancer."

NEW YORK (GenomeWeb News) – Several Texas biomedical science centers have received millions in new funding from the Cancer Prevention and Research Institute of Texas to support a wide range of studies, including 'omics-based projects, aimed at preventing, diagnosing, treating, and understanding c

The network will function as a "conduit" for academic researchers, community physicians, biotechnology companies, and drug manufacturers "to increase the pace of clinical oncology research by testing novel concepts, drugs, diagnostics, and medical devices," and provide state-of-the art care to patients in Texas, CTNET said.

The award will enable Rules-Based Medicine to add to its OncologyMAP panel immunoassays for 150 to 180 blood-based protein biomarkers associated with cancer.

The $3 million award will go toward developing and validating multiplexed immunoassays that measure 150 to 180 blood-based biomarkers that the National Cancer Institute believes may be associated with cancer.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.